AusperBio Receives Breakthrough Therapy Designation for AHB-137 in Chronic Hepatitis B Treatment
AHB-137 gains Breakthrough Therapy Designation (BTD) from the NMPA based on Phase 1/Phase2a clinical trial data demonstrating safety and efficacy.BTD…
